![conference banner](/images/conference-banner.jpeg)
Abstract
Aims: Develop a novel murine models of malignant pancreatitis.
Background: Although patients with chronic pancreatitis are at a greater risk of developing pancreatic cancer, there is no definitive mouse model that currently develops chronic pancreatitis-induced pancreatic cancer.
Objective: Characterization of eosinophilic inflammation-mediated malignant pancreatitis in novel murine model.
Methods: We developed a murine model of chronic eosinophilic inflammation associated with pancreatitis that also shows characteristic features of pancreatic malignancy. The mouse received cerulein and azoxymethane via intraperitoneal administration developed pathological malignant phenotype, as well as concomitant lung inflammation.
Results: We discovered pathological alterations in the pancreas that were associated with chronic pancreatitis, including a buildup of eosinophilic inflammation. Eosinophil degranulation was reported nearby in the pancreas tissue sections that show acinar-to-ductal metaplasia and acinar cell atrophy, both of which are characteristic of pancreatic malignancies. Additionally, we also observed the formation of PanIN lesions after three initial doses of AOM and eight weeks of cerulein with the AOM treatment regimen. We discovered that persistent pancreatic eosinophilic inflammation linked with a pancreatic malignant phenotype contributes to pulmonary damage. The RNA seq analysis also confirmed the induction of fibro-inflammatory and oncogenic proteins in pancreas and lung tissues. Further, in the current manuscript, we now report the stepwise kinetically time-dependent cellular inflammation, genes and proteins involved in the development of pancreatitis malignancy and associated acute lung injury by analyzing the mice of 3 AOM with 3, 8, and 12 weeks of the cerulein challenged protocol regime.
Conclusion: We first show that sustained long-term eosinophilic inflammation induces time-dependent proinflammatory, profibrotic and malignancy-associated genes that promote pancreatic malignancy and acute lung injury in mice.
Keywords: Acute lung injury, azoxymethane, cerulein, chronic pancreatitis, eosinophils, fibrosis, malignancy.
[http://dx.doi.org/10.1016/S0140-6736(20)31318-0] [PMID: 32798493]
[http://dx.doi.org/10.1097/00075198-200204000-00012] [PMID: 12386518]
[http://dx.doi.org/10.1152/ajpgi.00210.2017] [PMID: 28935682]
[http://dx.doi.org/10.1007/s10620-017-4817-2] [PMID: 29086330]
[http://dx.doi.org/10.3892/ijo.2015.3282] [PMID: 26647741]
[PMID: 32416712]
[http://dx.doi.org/10.1186/s12964-020-00594-x] [PMID: 32552827]
[http://dx.doi.org/10.15226/2374-815X/5/1/001109] [PMID: 29756031]
[http://dx.doi.org/10.1038/nrgastro.2017.12] [PMID: 28270694]
[http://dx.doi.org/10.1016/j.jaci.2018.02.011] [PMID: 29499224]
[http://dx.doi.org/10.1038/ajg.2011.328] [PMID: 21946280]
[http://dx.doi.org/10.3322/canjclin.53.4.245] [PMID: 12924777]
[http://dx.doi.org/10.1111/j.1745-7254.2007.00695.x] [PMID: 17723178]
[http://dx.doi.org/10.1159/000201251] [PMID: 7544747]
[http://dx.doi.org/10.1172/jci.insight.135591] [PMID: 32213713]
[http://dx.doi.org/10.1016/j.ccell.2016.04.014] [PMID: 27265504]
[http://dx.doi.org/10.1016/j.imlet.2019.08.006] [PMID: 31454522]
[http://dx.doi.org/10.3389/fonc.2021.657008]
[http://dx.doi.org/10.26508/lsa.202000979] [PMID: 34183442]
[http://dx.doi.org/10.1073/pnas.1717802115] [PMID: 29351990]
[http://dx.doi.org/10.1186/s40001-021-00567-x] [PMID: 34391478]
[http://dx.doi.org/10.1038/s41598-020-69899-8] [PMID: 32764696]
[http://dx.doi.org/10.1097/CCM.0000000000001639] [PMID: 26963319]
[http://dx.doi.org/10.1016/j.cytogfr.2019.05.003] [PMID: 31126874]
[http://dx.doi.org/10.1007/s00535-017-1390-6] [PMID: 28921377]
[http://dx.doi.org/10.1016/j.lfs.2021.119640] [PMID: 34048812]
[http://dx.doi.org/10.1158/0008-5472.CAN-08-1320] [PMID: 18829536]
[http://dx.doi.org/10.1126/scitranslmed.aat3487] [PMID: 30355799]
[http://dx.doi.org/10.1515/med-2018-0028] [PMID: 29756054]
[http://dx.doi.org/10.1038/s41598-020-64356-y] [PMID: 32355273]
[http://dx.doi.org/10.18632/oncotarget.13175] [PMID: 27835867]
[http://dx.doi.org/10.18632/oncotarget.22879] [PMID: 29416706]
[http://dx.doi.org/10.1158/1078-0432.CCR-06-1207] [PMID: 17289882]
[http://dx.doi.org/10.1097/MPA.0000000000000526] [PMID: 26646275]
[http://dx.doi.org/10.1007/s00018-019-03095-4] [PMID: 30982078]
[http://dx.doi.org/10.2147/OTT.S107771] [PMID: 27621649]
[http://dx.doi.org/10.1186/1471-230X-10-68] [PMID: 20587030]
[http://dx.doi.org/10.3389/fonc.2021.641289] [PMID: 34094925]
[http://dx.doi.org/10.1016/j.pan.2013.03.010] [PMID: 23719603]
[http://dx.doi.org/10.1016/j.canlet.2015.03.014] [PMID: 25779676]
[http://dx.doi.org/10.1038/s42003-021-02193-z] [PMID: 34099862]
[http://dx.doi.org/10.1158/1078-0432.CCR-13-0525] [PMID: 23653148]
[http://dx.doi.org/10.1158/1078-0432.CCR-08-1520] [PMID: 19088020]
[http://dx.doi.org/10.1186/1479-5876-10-68] [PMID: 22472349]
[http://dx.doi.org/10.3904/kjim.2017.133] [PMID: 29117667]
[PMID: 32603049]
[http://dx.doi.org/10.1038/s41392-021-00636-x] [PMID: 34023857]
[http://dx.doi.org/10.3389/fgene.2021.632803] [PMID: 34276760]
[http://dx.doi.org/10.1038/srep01870] [PMID: 23694968]
[http://dx.doi.org/10.1371/journal.pone.0161480] [PMID: 27561093]
[http://dx.doi.org/10.18632/oncotarget.9512] [PMID: 27223086]
[http://dx.doi.org/10.1054/bjoc.2001.1813] [PMID: 11401320]
[http://dx.doi.org/10.1080/15548627.2019.1628540] [PMID: 31177911]
![Wayfinder Image](/images/wayfinder.jpg)